VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 229 filers reported holding VERACYTE INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $578 | -12.4% | 25,872 | -0.2% | 0.03% | -6.1% |
| Q2 2023 | $660 | +6.5% | 25,915 | -6.8% | 0.03% | +17.9% |
| Q1 2023 | $620 | -5.8% | 27,792 | +0.3% | 0.03% | -12.5% |
| Q4 2022 | $658 | -99.9% | 27,713 | -0.2% | 0.03% | +45.5% |
| Q3 2022 | $462,000 | +6.7% | 27,757 | +27.6% | 0.02% | +15.8% |
| Q2 2022 | $433,000 | +13.4% | 21,758 | +56.8% | 0.02% | +26.7% |
| Q1 2022 | $382,000 | -33.2% | 13,875 | 0.0% | 0.02% | -16.7% |
| Q4 2021 | $572,000 | -16.3% | 13,875 | -5.6% | 0.02% | -18.2% |
| Q3 2021 | $683,000 | +11.8% | 14,700 | -3.7% | 0.02% | +10.0% |
| Q2 2021 | $611,000 | -25.3% | 15,267 | +0.2% | 0.02% | -31.0% |
| Q1 2021 | $818,000 | +24.5% | 15,235 | -35.2% | 0.03% | +93.3% |
| Q4 2019 | $657,000 | -52.5% | 23,500 | -59.2% | 0.02% | -51.6% |
| Q3 2019 | $1,383,000 | -16.9% | 57,600 | -1.4% | 0.03% | -18.4% |
| Q2 2019 | $1,665,000 | +13.8% | 58,400 | -0.2% | 0.04% | +26.7% |
| Q1 2019 | $1,463,000 | – | 58,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |